Biogen to start shipping new Alzheimer's drug in two weeks
More than 900 clinics and hospitals around the US are ready to administer Biogen's recently-approved drug Aduhelm to Alzheimer's patients.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Significantly more infusion centers than expected are ready to give patients suffering from Alzheimer's disease Biogen's new medication Aduhelm, according to Fiercepharma.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bogus drugs and medical equipment abound in Europe
For subscribers
.jpg&w=384&q=75)
